Family · Pharmaceutical analytical standards
Epalrestat
An aldose reductase inhibitor for diabetic neuropathy, developed in Japan and first approved in 1992: it blocks the polyol pathway, which at high blood sugar turns glucose into sorbitol that builds up in nerves. It is also used in China and India. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its molecule contains a rhodanine ring, a chemical group unusual for a medicine: medicinal chemists usually view it with suspicion, because it tends to bind to many different proteins.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
